0001213900-23-048683.txt : 20230613 0001213900-23-048683.hdr.sgml : 20230613 20230613205421 ACCESSION NUMBER: 0001213900-23-048683 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230613 FILED AS OF DATE: 20230613 DATE AS OF CHANGE: 20230613 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Mahal Jeetinder Singh CENTRAL INDEX KEY: 0001882877 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39138 FILM NUMBER: 231012785 MAIL ADDRESS: STREET 1: C/O JASPER THERAPEUTICS, INC. STREET 2: 2200 BRIDGE PARKWAY, SUITE 102 CITY: REDWOOD CITY STATE: CA ZIP: 94065 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Jasper Therapeutics, Inc. CENTRAL INDEX KEY: 0001788028 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 842984849 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2200 BRIDGE PKWY SUITE #102 CITY: REDWOOD CITY STATE: CA ZIP: 94065 BUSINESS PHONE: 6505491400 MAIL ADDRESS: STREET 1: 2200 BRIDGE PKWY SUITE #102 CITY: REDWOOD CITY STATE: CA ZIP: 94065 FORMER COMPANY: FORMER CONFORMED NAME: Amplitude Healthcare Acquisition Corp DATE OF NAME CHANGE: 20190912 4 1 ownership.xml X0407 4 2023-06-13 0 0001788028 Jasper Therapeutics, Inc. JSPR 0001882877 Mahal Jeetinder Singh C/O JASPER THERAPEUTICS, INC. 2200 BRIDGE PARKWAY, SUITE 102 REDWOOD CITY CA 94065 0 1 0 0 See Remarks 1 Voting Common Stock 2023-06-13 4 M 0 9000 0.71 A 296223 D Voting Common Stock 2023-06-13 4 S 0 9000 1.6572 D 287223 D Stock Option (right to buy) 0.71 2023-06-13 4 M 0 9000 0.00 A 2030-05-31 Voting Common Stock 9000 173713 D The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 15, 2023. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.62 to $1.69, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price. 25% of the original number of shares subject to the option vested on December 12, 2020, and 1/48th of the original number of shares have vested and shall vest monthly thereafter, subject to the Reporting Person's continued service to the Issuer through each such vesting date. Chief Operating Officer, Chief Financial Officer and Corporate Secretary /s/ Jeet Mahal 2023-06-13